Sexually transmitted diseases and infections

Risk factors for HIV vary between African cities, need tailored responses

A comparative study in three large cities in southern Africa has found big differences in risk factors for acquisition of HIV infection, emphasising the importance of locally tailored HIV prevention strategies and up-to-date information on local risk factors.

The study looked at behavioural risk factors associated with acquiring HIV infection in 5000 sexually active women in Harare, Durban and Johannesburg who took part in a large trial of an HIV prevention method based on use of the diaphgram.

Sue Napierala Mavedsnege and colleagues report the findings of their prospective cohort analysis in the advance online edition of the Journal of Acquired Immune Deficiency Syndromes. 

A total of 309 incident HIV infections were identified. Durban reported the highest incidence rate, followed by Johannesburg and then Harare (6.75 per 100 person years, 95% CI: 5.74-7.93; 3.33 per 100 person years, 95% CI: 2.51-4.44; 2.72 per 100 person years CI: 2.26-3.26, respectively).

Having more than one partner in the last three months was the only common factor associated with HIV incidence.

The majority of the estimated 35 million people living with HIV live in sub-Saharan Africa where 70% of all new infections occur. Women represent over 60% of all infections. Southern Africa, with the highest regional prevalence, reflects different phases of the epidemic.

In Zimbabwe, with an estimated prevalence of 14.3%, the epidemic began early, peaked in 1998 with a subsequent decline in incidence and prevalence.

From 1990-1998 South Africa had an exponential increase followed by a moderate increase until 2004 when apparent stabilisation began. In 2008 estimated provincial prevalence rates ranged from 5.3% to 25.8%.

In Gauteng province, with Johannesburg its largest city, prevalence appears to have peaked in 2002 at 20.3% and declined to 15.2% in 2008. In contrast, Kwa Zulu Natal province where Durban is the largest city, estimated prevalence rose from 15.7% in 2002 to 25.8% in 2008.

While cross-sectional studies looking at risk factors associated with HIV have taken place in Zimbabwe and South Africa, few have looked at risk factors for HIV incidence in women.  A better understanding of these factors within local contexts will help develop targeted interventions so reducing transmission.

The authors looked at factors associated with differences of HIV incidence among women in Harare, Johannesburg and Durban enrolled between September 2003 and September 2005 in the Methods for Improvement of Reproductive Health (MIRA) study, a randomised clinical trial to look at the effect of the diaphragm plus lubricant gel for the prevention of HIV. The intervention did not reduce HIV incidence.

The authors undertook a prospective cohort analysis of trial participants who were followed for a median of 21 months (12-24 months).

Socio-demographic, biological and behavioural data were collected at baseline and at quarterly visits. Testing for HIV and STIs were conducted at each quarterly visit.

Each location had distinct characteristics as well as different patterns of individual risk factors.

In Harare women were more likely to live with their partner, be employed and not use alcohol or drugs but more likely to wipe inside their vagina. While they had a later sexual debut and fewer partners than in Durban or Johannesburg there was more transactional sex (for money, food, drugs or shelter) within the last three months.

Early sexual debut was more common in Durban, while in Johannesburg consumption of alcohol within the last three months, multiple sexual partners and sex under the influence of drugs or alcohol were more likely.

Sexually transmitted infections (STIs) were important risk factors in Harare and Durban (prevalent herpes simplex virus AHR=2.56, 95% C: 1.61-4.06; incident herpes simplex virus AHR= 12.6, 95% CI: 2.13-21.87; gonorrhoea AHR=6.82, 95% CI: 2.13-21.87 and prevalent herpes simplex AHR=1.64, 95% CI: 1.07-2.52; gonorrhoea AHR=4.40, 95% I: 2.07-9.39, respectively.

Multiple partners and sex with a partner under the influence of alcohol or drugs significant increased the risk in Durban (AOR=1.78, 95% CI: 1.11-2.85 and AOR= 1.51, 95% CI: 1.05-2.16, respectively, whereas in Johannesburg early sexual debut was a strong predictors of getting HIV(AOR= 2.60, 95% CI: 1.30-5.17).

In Harare and Johannesburg 20.2 % and 22.3% of HIV infections, respectively, were attributable to wiping inside the vagina. Wiping inside the vagina has been independently associated with decreased condom use

In Harare over 96% of women were living with their partner; the median number of lifetime partners was 1.3. This implies, note the authors, most HIV infection was acquired from their live-in partner, yet 25% did not know their partner’s status.

The authors note the strengths of the study include its longitudinal study design and large sample size.

A limitation is that the study was conducted among clinical trial participants with strict eligibility criteria.

The authors suggest “as an epidemic matures more transmission occurs within stable partnerships, and we may see this...in South Africa. As the epidemic wanes, as… in Zimbabwe, we may begin to see…HIV transmission among young people and high risk core groups become increasingly important drivers of the epidemic.”

The significant differences in drivers of HIV incidence in the three locations support targeted HIV programming based on the local situation and epidemiology as the most effective approach to reduce HIV incidence among women, the authors conclude.

Reference

Napierala Mavedzenge S et al. Determinants of differential HIV incidence among women in three southern African locations. JAIDS advance online edition, doi: 10.1097/QAI.0b013e3182254038, 2011.

Rich rewards for five female researchers

FIVE female scientists, from Stellenbosch University and UCT, are among a group of 10 “inspiring women scientists” who have been honoured with 2011 L’Oréal-Unesco Regional Fellowships For Women in Science.

The ceremony took place in Joburg last night.

The L’Oréal Corporate Foundation created the For Women in Science partnership with Unesco in 1998, and since then more than 1 000 women scientists across the world have received awards or support in pursuing their careers, through various fellowship programmes.

Each of last night’s winners receive R180 000 towards the completion of their PhDs in the fields of microbiology, environmental science, medical virology, chemistry and agriculture.

The local recipients are:

lDalene de Swardt, 31, is doing her PhD in medical virology at Stellenbosch University.

She said her research, in the field of HIV/Aids, focused on a specific immune cell, the dendritic cell.

Swardt explained that the cells contributed towards the activation of the immune system, and that she was investigating what happened to these cells in people with HIV.

She was developing a natural agent that she hoped would block HIV from entering healthy cells, while also curbing the activation status of the HIV virus “so that it (the agent) can attack and clear out the infection”.

l Jeanne de Waal, 27, who is doing her PhD in agricultural sciences, also at Stellenbosch.

De Waal said she grew up in Pretoria and had to swop her high heels for gumboots when she began her studies, “but it is quite fun being a girl in the field of agriculture”.

Receiving the award was a great honour, she said, adding that it was a wonderful reward for her hard work and long hours spent working on her PhD.

De Waal is looking at environmentally friendly pest management practices, and is developing a biological pest control agent (a worm) to effectively control pests on apples and pears.

She said that biological control agents were already commercialised in parts of Europe and the US, but not in South Africa.

“We want to develop agents that are endemic to South Africa because insects are building up resistance to antibiotics and pest control.”

De Waal added that the demand for organic and sustainably produced food had also helped drive the process towards more environmentally friendly pest control management.

l Kim Trollope, 34, is focusing on yeast microbiology for her PhD. Her research focuses on producing an enzyme used for the production of sweeteners from cane sugar (sucrose).

The sweeteners are lower in calories and safe for use by diabetics. Trollope explained that her PhD would supplement existing work being done in this regard, by potentially providing an understanding of how the enzyme functioned, and by producing a novel enzyme with improved properties.

All three said they would use the money to attend international conferences which were important for networking with others in their field.

l The other two fellowship recipients, Olutayo K Boyinbode, 37, from Nigeria, and Rachel Muigai, from Kenya, both live in Cape Town and are studying at UCT.

Boyinbode is completing her PhD in computer science.

Muigai’s PhD is focusing on the sustainability of concrete structures.

Older ARVs associated with premature ageing

NAIROBI, 27 June 2011 (PlusNews) - Certain antiretroviral (ARV) drugs commonly used in the developing world may be responsible for premature ageing, according to the authors of a new study published in the journal, Nature Genetics. Newer, less toxic but more expensive ARVs are more commonly used in the Western world.

Nucleoside analogue reverse-transcriptase inhibitors (NRTIs) - including Zidovudine, Lamivudine and Abacavir - have enabled millions of people living with HIV to prolong their lives. The UN World Health Organization has recommended that countries phase out Stavudine, an NRTI commonly used in Africa, due to long-term, irreversible side effects.

"We noticed that people in their 40s who had been on NRTIs for the past several years had signatures of ageing in their muscles commonly found in healthy people in their 70s and 80s," said Prof Patrick Chinnery of the University of Newcastle in the UK, one of the study's lead authors.

The researchers studied skeletal muscle from 33 HIV-infected adults, all aged 50 years or under, and 10 uninfected control subjects of comparable age. They found that in patients on NRTI treatment there was an expansion in mutations of mitochondrial DNA - the energy-producing part of the cell - similar to the mutations found in healthy older individuals.

"What we saw in our study is similar to patterns described by people who have been on ART [antiretroviral therapy] for a long time," said Chinnery.

Studies have found that despite a significant drop in mortality, people living with HIV are often affected by an increased risk of non-AIDS complications, including osteoporosis and heart attacks, which undermine their life-expectancy.

"The findings suggest that we need to look carefully at the effects of these drugs because some of the diseases caused by the abnormalities - diabetes, heart failure and so on - are serious and can cause progressive disability," Chinnery noted.

"But at the same time, clearly the patients need their drugs in order to keep them alive... but our study suggests that it may be beneficial to move to newer classes of drugs."

Chinnery said there was a need to conduct prospective studies on the likely effects of long-term use of different ARVs in order to catch and address potentially harmful side effects.

My fertility was stolen from me

Series Name: 
Nursing Update
Published by: 
Democratic Nursing Organisation of South Africa

In Namibia, HIV-positive women are being tricked into sterilisation. Is this a country desperate to curb Aids, or just a blatant human rights violation? Marion Stevens of the Women and HIV/AIDS Gauge, Health Systems Trust, came across this recent article, which exposes the reality of what’s happening in Namibia’s state hospitals.

Mpilonhle Project

Mpilonhle Project is the community component for the HIV/AIDS anti-retroviral rollout (ARV) at Ladysmith Provincial Hospital in partnership with the Communicable Disease Clinic (CDC).The joint partnership is called Augmented Community HIV Action Project (ACHIVA), and is funded by Bristol-Myers Squibb (BMS) Secure the Future (STF) Program. Mpilonhle works to assist orphans and vulnerable children and people living with HIV and AIDS.

AIDS Law Project

Every day people living with HIV or AIDS face one problem after another because of discrimination. People struggle to get access to proper medical treatment, school for children and even work. It is difficult to buy a house because it is impossible to get insurance. Our children and families face harsh words from friends or colleagues. A LOT OF THIS DISCRIMINATION IS AGAINST THE LAW The AIDS Law Project (ALP) is at Wits University Centre for Applied Legal Studies. It is an organisation that specialises in helping people with HIV/AIDS to deal with these problems.

The Synergy Project

The Synergy Project is a five-year, performance-based contract that provides technical assistance and services to the United States Agency for International Development (USAID) to design, evaluate, and coordinate HIV/AIDS programs and identify and disseminate lessons learned from these programs. This website offers HIV/AIDS Technical and Programming resources including newsletter, links to HIV/AIDS focussed websites, publications and a calendar of events.